Treatment with granulocyte colony stimulating factor is associated with improvement in endothelial function

References

• Adamopoulos S, Parissis JT, et al. Effects of growth hormone on circulating cytokine network and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2003; 24(24)2186–2196
   Google Scholar
• Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, Technau-Ihling K, Zeiher AM, Dimmeler S. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370–1376
   PubMed Web of Science ®Google Scholar
• Anderlini P, Przepiorka D, Champlin R, Körbling M. Biologic and clinical effects of granulocyte colony stimulating factor in normal individuals. Blood 1996; 88: 2819–2825
   PubMed Web of Science ®Google Scholar
• Baum M, Ravdin PM. Decision-making in early breast cancer: Guidelines and decision tools. Eur J Cancer 2002; 38: 745–749
   PubMedGoogle Scholar
• Benoy I, Salgado R, Colpaert C, Weytjens R, Vermeulen PB, Dirix LY. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2002; 2: 311–315
   PubMed Web of Science ®Google Scholar
• Bhattacharya V, Shi Q, Atsushi I, Sauvage LR, Hammond WP. Administration of granulocyte colony-stimulating factor enhances endothelialization and microvessel formation in small-caliber synthetic vascular grafts. J Vasc Surg 2000; 32: 116–123
   PubMed Web of Science ®Google Scholar
• Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 2002; 13: 389–391
   Google Scholar
• Carstanjen D, Regenfus M, Muller C, Salama A. Interleukin-6 is a major effector molecule of short-term G-CSF treatment by inducing bone metabolism and an acute-phase response. Exp Hematol 2001; 29: 812–821
   Google Scholar
• Cho HJ, Kim HS, Lee MM, Kim DH, Yang HJ, Hur J, Hwang KK, Oh S, Choi YJ, Chae IH, Oh BH, Choi YS, Walsh K, Park YB. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003; 108: 2918–2925
   PubMed Web of Science ®Google Scholar
• de Muinck ED, Simons M. Calling on reserves: Granulocyte colony stimulating growth factor in cardiac repair. Circulation 2005; 112: 3033–3035
   Google Scholar
• Dupont WD, Plummer WD. ‘Power and sample size calculations: A review and computer program. Control Clin Trials 1990; 11: 116–128
   PubMedGoogle Scholar
• Duquaine D, Hirsch GA, Chakrabarti A, Han Z, Kehrer C, Brook R, Joseph J, Schott A, Kalyanaraman B, Vasquez-Vivar J, Rajagopalan S. Rapid-onset endothelial dysfunction with adriamycin: Evidence for a dysfunctional nitric oxide synthase. Vasc Med 2003; 8: 101–107
   PubMed Web of Science ®Google Scholar
• Eissner G, Lindner H, Reisbach G, Klauke I, Holler E. Differential modulation of IL-1 induced endothelial adhesion molecules and transendothelial migration of granulocytes by G-CSF. Br J Haematol 1997; 97: 726–733
   Google Scholar
• Fichtlscherer S, Breuer S, Heeschen C, Dimmeler S, Zeiher AM. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease. J Am Coll Cardiol 2004; 44: 44–49
   PubMed Web of Science ®Google Scholar
• Gunnett CA, Heistad DD, Faraci FM. Interleukin-10 protects nitric oxide-dependent relaxation during diabetes: Role of superoxide. Diabetes 2002; 51: 1931–1937
   Google Scholar
• Harada M, Qin Y, Takano H, Minamino T, Zou Y, Toko H, Ohtsuka M, Matsuura K, Sano M, Nishi J, Iwanaga K, Akazawa H, Kunieda T, Zhu W, Hasegawa H, Kunisada K, Nagai T, Nakaya H, Yamauchi-Takihara K, Komuro I. G-CSF prevents cardiac remodelling after myocardial infarction by activating the Jak–Stat pathway in cardiomyocytes. Nat Med 2005; 11: 305–311
   PubMed Web of Science ®Google Scholar
• Hartung T, Docke WD, Gantner F, Krieger G, Sauer A, Stevens P, Volk HD, Wendel A. Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood 1995; 85: 2482–2489
   PubMed Web of Science ®Google Scholar
• Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T. Circulating endothelial progenitor cells, vascular function and cardiovascular risk. N Engl J Med 2003; 348: 593–600
   PubMed Web of Science ®Google Scholar
• Hill JM, Syed MA, Arai AE, Powell TM, Paul JD, Zalos G, Read EJ, Khuu HM, Leitman SF, Horne M, Csako G, Dunbar CE, Waclawiw MA, Cannon RO, 3rd. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coll Cardiol 2005; 46: 1643–1648
   PubMed Web of Science ®Google Scholar
• Ikonomidis I, Athanassopoulos G, Lekakis J, Venetsanou K, Marinou M, Stamatelopoulos K, Cokkinos DV, Nihoyannopoulos P. Myocardial ischemia induces interleukin-6 and tissue factor production in patients with coronary artery disease: A dobutamine stress echocardiography study. Circulation 2005; 112: 3272–3279
   PubMed Web of Science ®Google Scholar
• Ince H, Petzsch M, Kleine HD, Schmidt H, Rehders T, Korber T, Schumichen C, Freund M, Nienaber CA. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 2005; 112: 3033–3035
   Google Scholar
• Iversen PO, Nicolaysen A, Kvernebo K, Benestad HB, Nicolaysen G. Human cytokines modulate arterial vascular tone via endothelial receptors. Pflügers Arch-Eur J Physiol 1999; 439: 93–100
   PubMed Web of Science ®Google Scholar
• Joseph J, Rimawi A, Mehta P, Cottler-Fox M, Sinha A, Singh BK, Pacheco R, Smith ES, 3rd, Mehta JL. Safety and effectiveness of granulocyte-colony stimulating factor in mobilizing stem cells and improving cytokine profile in advanced chronic heart failure. Am J Cardiol 2006; 97: 681–684
   PubMed Web of Science ®Google Scholar
• Kang HJ, Kim HS, Zhang SY, Park KW, Cho HJ, Koo BK, Kim YJ, Soo Lee D, Sohn DW, Han KS, Oh BH, Lee MM, Park YB. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomised clinical trial. Lancet 2004; 363: 751–756
   PubMed Web of Science ®Google Scholar
• Lee M, Aoki M, Kondo T, Kobayashi K, Okumura K, Komori K, Murohara T. Therapeutic angiogenesis with intramuscular injection of low-dose recombinant granulocyte-colony stimulating factor. Arterioscler Thromb Vasc Biol 2005; 25: 2535–2541
   Google Scholar
• Lekakis JP, Ikonomidis I, Tsibida M, Protogerou A, Papada A, Papapanagiotou A, Revela I, Papamichael CM, Kalofoutis AT, Kremastinos DT. Genetic variations of the endothelial nitric oxide synthase gene are related to increased levels of C-reactive protein and macrophage-colony stimulating-factor in patients with coronary artery disease. Thromb Haemost 2006; 96: 520–528
   Google Scholar
• Lenk K, Adams V, Lurz P, Erbs S, Linke A, Gielen S, Schmidt A, Scheinert D, Biamino G, Emmrich F, Schuler G, Hambrecht R. Therapeutical potential of blood progenitor cells in patients with peripheral arterial occlusive disease and critical limb ischemia. Eur Heart J 2005; 26: 1903–1909
   PubMed Web of Science ®Google Scholar
• Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infracted heart, improving function and survival. Proc Natl Acad Sci U S A 2001; 98: 10344–10349
   PubMed Web of Science ®Google Scholar
• Ozuyaman B, Ebner P, Niesler U, Ziemann J, Kleinbongard P, Jax T, Godecke A, Kelm M, Kalka C. Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 2005; 94: 770–772
   PubMed Web of Science ®Google Scholar
• Piccart MJ, van de Velde C, Straehle C. The EORTC strategy for the early 2000's. Clin Breast Cancer 2000; 1: 166–167
   Google Scholar
• Raitakari OT, Celermajer DS. Flow-mediated dilatation. Br J Clin Pharmacol 2000; 50(5)397–404
   PubMed Web of Science ®Google Scholar
• Sesti C, Hale SL, Lutzko C, Kloner RA. Granulocyte colony-stimulating factor and stem cell factor improve contractile reserve of the infracted left ventricle independent of restoring muscle mass. J Am Coll Cardiol 2005; 46: 1662–1669
   PubMedGoogle Scholar
• Spuck S, Schaaf B, Wiedorn KH, Hansen F, Vollmer E, Dalhoff K, Braun J. G-CSF application in patients with severe bacterial pneumonia increases IL-10 expression in neutrophils. Respir Med 2003; 97: 51–58
   Google Scholar
• Stamatelopoulos KS, Lekakis JP, Poulakaki NA, Papamichael CM, Venetsanou K, Aznaouridis K, Protogerou AD, Papaioannou TG, Kumar S, Stamatelopoulos SF. Tamoxifen improves endothelial function and reduces carotid intima-media thickness in postmenopausal women. Am Heart J 2004; 147: 1093–1099
   PubMed Web of Science ®Google Scholar
• Tedgui A, Mallat Z. Anti-inflammatory mechanisms in the vascular wall. Circ Res 2001; 88: 877–887
   PubMed Web of Science ®Google Scholar
• Wæhre T, Halvorsen B, Damås JK, Yndestad A, Brosstad F, Gullestad L, Kjekshus J, Frøland SS, Aukrust P. Inflammatory imbalance between IL-10 and TNF-α in unstable angina potential plaque stabilizing effects of IL-10. Eur J of Clin Invest 2002; 32: 803–810
   PubMed Web of Science ®Google Scholar
• Xu S, Hoglund M, Hakansson L. Granulocyte colony stimulating factor-G-CSF induces production of cytokines in vivo. Br J Haematol 2000; 108: 848–853
   PubMed Web of Science ®Google Scholar
• Yong KL. Granulocyte colony stimulating factor-G-CSF increases neutrophil migration across vascular endothelium independent of an effect of adhesion: Comparison with granulocyte-macrophage colony stimulating factor-GM-CSF. Br J Haematol 1996; 94: 40–47
   Google Scholar